250 related articles for article (PubMed ID: 24844804)
1. Solvent/detergent plasma: pharmaceutical characteristics and clinical experience.
Liumbruno GM; Franchini M
J Thromb Thrombolysis; 2015 Jan; 39(1):118-28. PubMed ID: 24844804
[TBL] [Abstract][Full Text] [Related]
2. Solvent/detergent-treated plasma: a tale of 30 years of experience.
Liumbruno GM; Marano G; Grazzini G; Capuzzo E; Franchini M
Expert Rev Hematol; 2015 Jun; 8(3):367-74. PubMed ID: 25695198
[TBL] [Abstract][Full Text] [Related]
3. Robustness of solvent/detergent treatment of plasma derivatives: a data collection from Plasma Protein Therapeutics Association member companies.
Dichtelmüller HO; Biesert L; Fabbrizzi F; Gajardo R; Gröner A; von Hoegen I; Jorquera JI; Kempf C; Kreil TR; Pifat D; Osheroff W; Poelsler G
Transfusion; 2009 Sep; 49(9):1931-43. PubMed ID: 19497061
[TBL] [Abstract][Full Text] [Related]
4. Solvent/detergent-treated plasma: composition, efficacy, and safety.
Hellstern P
Curr Opin Hematol; 2004 Sep; 11(5):346-50. PubMed ID: 15666659
[TBL] [Abstract][Full Text] [Related]
5. Inactivation and Removal of Chikungunya Virus and Mayaro Virus from Plasma-derived Medicinal Products.
Yue C; Teitz S; Miyabashi T; Boller K; Lewis-Ximenez LL; Baylis SA; Blümel J
Viruses; 2019 Mar; 11(3):. PubMed ID: 30866548
[TBL] [Abstract][Full Text] [Related]
6. Recovery, safety, and tolerability of a solvent/detergent-treated and prion-safeguarded transfusion plasma in a randomized, crossover, clinical trial in healthy volunteers.
Jilma-Stohlawetz P; Kursten FW; Horvath M; Leitner G; List J; Marcek J; Quehenberger P; Schwameis M; Bartko J; Derhaschnig U; Jilma B
Transfusion; 2013 Sep; 53(9):1906-17. PubMed ID: 23320451
[TBL] [Abstract][Full Text] [Related]
7. [Solvent-detergent viral inactivation of minipools of plasma for transfusion, cryoprecipitate and cryo-poor plasma in single-use bag systems].
Burnouf T; Goubran HA; Radosevich M; El-Ekiaby M
Transfus Clin Biol; 2008 Jun; 15(3):129-34. PubMed ID: 18538608
[TBL] [Abstract][Full Text] [Related]
8. Enveloped virus inactivation by caprylate: a robust alternative to solvent-detergent treatment in plasma derived intermediates.
Korneyeva M; Hotta J; Lebing W; Rosenthal RS; Franks L; Petteway SR
Biologicals; 2002 Jun; 30(2):153-62. PubMed ID: 12127317
[TBL] [Abstract][Full Text] [Related]
9. [Clinical use of virally inactived plasma. The experience of Blood Transfusion Unit in Mantova, Italy].
Lepri D; Capuzzo E; Mattioli AV; Dall'Oglio D; Sgarioto V; Terenziani I; Caramaschi G; Manzato F; Franchini M
Recenti Prog Med; 2013 Mar; 104(3):106-11. PubMed ID: 23548954
[TBL] [Abstract][Full Text] [Related]
10. Acute haemolytic transfusion reaction after transfusion of fresh frozen plasma in a neonate-Preventable by using solvent/detergent-treated pooled plasma?
Henricks LM; Huisman EJ; Lopriore E; Luken JS; de Haas M; Ootjers CS; Albersen A
Transfus Med; 2023 Apr; 33(2):174-178. PubMed ID: 36257670
[TBL] [Abstract][Full Text] [Related]
11. False-positive pregnancy test after transfusion of solvent/detergent-treated plasma.
Jilma-Stohlawetz P; Wreford-Bush T; Mills F; Davidson F; Kursten FW; Jilma B; Birchall J
Transfusion; 2017 Dec; 57(12):2965-2968. PubMed ID: 28905381
[TBL] [Abstract][Full Text] [Related]
12. Virus inactivation in a factor VIII/VWF concentrate treated using a solvent/detergent procedure based on polysorbate 20.
Roberts PL; Lloyd D; Marshall PJ
Biologicals; 2009 Jan; 37(1):26-31. PubMed ID: 18848782
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of virus in intravenous immunoglobulin G using solvent/detergent treatment and pasteurization.
Aghaie A; Pourfatollah AA; Bathaie SZ; Moazzeni SM; Khorsand Mohammad Pour H; Sharifi Z
Hum Antibodies; 2008; 17(3-4):79-84. PubMed ID: 19029665
[TBL] [Abstract][Full Text] [Related]
14. SARS-coronavirus (SARS-CoV) and the safety of a solvent/detergent (S/D) treated immunoglobulin preparation.
Rabenau HF; Biesert L; Schmidt T; Bauer G; Cinatl J; Doerr HW
Biologicals; 2005 Jun; 33(2):95-9. PubMed ID: 15939287
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of Zika virus by solvent/detergent treatment of human plasma and other plasma-derived products and pasteurization of human serum albumin.
Kühnel D; Müller S; Pichotta A; Radomski KU; Volk A; Schmidt T
Transfusion; 2017 Mar; 57(3pt2):802-810. PubMed ID: 28019034
[TBL] [Abstract][Full Text] [Related]
16. Comparable virus inactivation by bovine or vegetable derived Tween 80 during solvent/detergent treatment.
Seitz H; Blümel J; Schmidt I; Willkommen H; Löwer J
Biologicals; 2002 Sep; 30(3):197-205. PubMed ID: 12217344
[TBL] [Abstract][Full Text] [Related]
17. Proteomic characterization of freeze-dried human plasma: providing treatment of bleeding disorders without the need for a cold chain.
Steil L; Thiele T; Hammer E; Bux J; Kalus M; Völker U; Greinacher A
Transfusion; 2008 Nov; 48(11):2356-63. PubMed ID: 18657073
[TBL] [Abstract][Full Text] [Related]
18. Thirty years of experience with solvent/detergent-treated plasma for transfusion medicine.
Racine-Brzostek SE; Cushing MM; Gareis M; Heger A; Mehta Shah T; Scully M
Transfusion; 2024 Jun; 64(6):1132-1153. PubMed ID: 38644541
[No Abstract] [Full Text] [Related]
19. Thawed solvent/detergent-treated plasma demonstrates comparable clinical efficacy to thawed plasma.
Racine-Brzostek SE; Canver MC; DeSimone RA; Zdravkova M; Lo DT; Crowley KM; Hsu YS; Vasovic LV; Hill SS; Cushing MM
Transfusion; 2020 Sep; 60(9):1940-1949. PubMed ID: 32720432
[TBL] [Abstract][Full Text] [Related]
20. Safety procedures of coagulation factors.
Jorquera JI
Haemophilia; 2007 Dec; 13 Suppl 5(Suppl 5):41-6. PubMed ID: 18078396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
